{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:11:56Z","timestamp":1777896716906,"version":"3.51.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> Pancreatic undifferentiated carcinoma accounts for 2%\u20137% of pancreatic carcinomas. We aimed to investigate the pathological and genetic characteristics of pancreatic undifferentiated carcinoma with osteoclast-like giant cells and the key points of treatment.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The clinical data and follow-up results of four patients diagnosed with pancreatic undifferentiated carcinoma with osteoclast-like giant cells between May 2015 and May 2020 at the First Affiliated Hospital of Xi\u2019an Jiaotong University were retrospectively analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Chief complaints included \u201cpain and discomfort in the upper abdomen\u201d (2\/4), \u201cnausea and vomiting\u201d (1\/4) or no symptoms (1\/4). Preoperative mildly elevated tumor markers included carcinoembryonic antigen (1\/4) and CA19-9 (1\/4). The tumors were located in the tail of the pancreas in three patients and the head and neck in one patient. Tumor metastasis was found in pancreatic adipose tissue in two patients and lymph node metastasis in one patient, with microscopic heterogeneous mononuclear cells and scattered osteoclast-like giant cells of various sizes. One patient (1\/4) had a mucinous cystic tumor of the pancreas, and two patients (2\/4) had adenocarcinoma of the pancreatic duct. Only one patient received postoperative gemcitabine combined with albumin-bound paclitaxel chemotherapy.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Currently, treatment guidelines are lacking for PUC-OGC, and prognosis varies markedly. More cases must be reported to clarify its origination. The long-term follow-up of diagnosed patients and genetic mutation testing can also contribute to improving treatment and prognosis of this disease.<\/jats:p>","DOI":"10.3389\/pore.2023.1610983","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T11:54:55Z","timestamp":1677844495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case report: Pathological and genetic features of pancreatic undifferentiated carcinoma with osteoclast-like giant cells"],"prefix":"10.3389","volume":"29","author":[{"given":"Ni","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/1097-0142(196808)22:2<333::aid-cncr2820220210>3.0.co;2-a","article-title":"Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin","volume":"22","author":"Rosai","year":"1968","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.prp.2008.11.006","article-title":"Undifferentiated pancreatic carcinoma with osteoclast-like giant cells: Report of a case with osteochondroid differentiation","volume":"205","author":"Manduch","year":"2009","journal-title":"Pathol Res Pract"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.18.00169","article-title":"Use of next-generation sequencing tests to guide cancer treatment: Results from a nationally representative survey of oncologists in the United States","volume":"2","author":"Freedman","year":"2018","journal-title":"Jco Precision Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/RLU.0000000000001719","article-title":"18F-FDG PET\/CT in the detection of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas","volume":"42","author":"Fu","year":"2017","journal-title":"Clin Nucl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.clinimag.2015.09.013","article-title":"Magnetic resonance imaging findings of undifferentiated carcinoma with osteoclast-like giant cells of pancreas","volume":"40","author":"Yang","year":"2016","journal-title":"Clin Imaging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000366045","article-title":"Radiological evaluation of focal pancreatic lesions","volume":"33","author":"Putzer","year":"2015","journal-title":"Dig Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/ng.1020","article-title":"Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations","volume":"44","author":"Wu","year":"2011","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/1066896912475073","article-title":"Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of divergent populations of tumor cells","volume":"21","author":"Visani","year":"2013","journal-title":"Int J Surg Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pharmthera.2016.09.003","article-title":"KRAS-related proteins in pancreatic cancer","volume":"168","author":"Mann","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-019-0996-7","article-title":"p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis","volume":"567","author":"Li","year":"2019","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/mpa.0b013e3181f95104","article-title":"Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma","volume":"40","author":"Grochola","year":"2011","journal-title":"Pancreas"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1056\/NEJMc1508163","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"373","author":"Chan","year":"2015","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/ijerph13090892","article-title":"Role of deficient mismatch repair in the personalized management of colorectal cancer","volume":"13","author":"Zhang","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1053\/j.gastro.2019.02.037","article-title":"Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might Be targeted with existing drugs or used as biomarkers","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1158\/1541-7786.MCR-17-0735","article-title":"Landscape of tumor mutation load, mismatch repair deficiency, and PD-L1 expression in a large patient cohort of gastrointestinal cancers","volume":"16","author":"Salem","year":"2018","journal-title":"Mol Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2008.03.056","article-title":"Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer","volume":"268","author":"Loos","year":"2008","journal-title":"Cancer Lett Sep 8"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/OTT.S66809","article-title":"The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer","volume":"7","author":"Chen","year":"2014","journal-title":"Onco Targets Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00268-010-0448-x","article-title":"Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma","volume":"34","author":"Wang","year":"2010","journal-title":"World J Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00432-008-0364-8","article-title":"B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression","volume":"134","author":"Geng","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"71198","DOI":"10.18632\/oncotarget.11685","article-title":"Prognostic value of PDL1 expression in pancreatic cancer","volume":"7","author":"Birnbaum","year":"2016","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.humpath.2018.07.006","article-title":"PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: Expression patterns and clinical implications","volume":"81","author":"Luchini","year":"2018","journal-title":"Hum Pathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-020-02830-8","article-title":"Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: Study of 13 cases comparing ductal pancreatic carcinoma and review of the literature","volume":"477","author":"Hrudka","year":"2020","journal-title":"Virchows Arch"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/jco.19.00946","article-title":"Potentially curable pancreatic adenocarcinoma: ASCO clinical Practice guideline update","volume":"37","author":"Khorana","year":"2019","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijscr.2014.01.002","article-title":"Osteoclastic giant cell tumor of the pancreas","volume":"5","author":"Temesgen","year":"2014","journal-title":"Int J Surg Case Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1200\/JCO.2018.78.9636","article-title":"Metastatic pancreatic cancer: ASCO clinical Practice guideline update","volume":"36","author":"Sohal","year":"2018","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.2169\/internalmedicine.51.7670","article-title":"Effective use of gemcitabine in the treatment of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas with portal vein tumor thrombus","volume":"51","author":"Yoshioka","year":"2012","journal-title":"Intern Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3748\/wjg.v21.i2.694","article-title":"Locally advanced undifferentiated carcinoma with osteoclast-like giant cells of the pancreas","volume":"21","author":"Gao","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B30","first-page":"433","article-title":"Giant cell tumor of the pancreas: A pathological diagnosis with poor prognosis","volume":"9","author":"Singhal","year":"2010","journal-title":"Hepatobiliary Pancreat Dis Int"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2023.1610983\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T11:55:00Z","timestamp":1677844500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2023.1610983\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":30,"alternative-id":["10.3389\/pore.2023.1610983"],"URL":"https:\/\/doi.org\/10.3389\/pore.2023.1610983","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"article-number":"1610983"}}